| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Doubletwist, Inc. |
| 1999 Harrison Street, Suite 1100, Oakland, CA 94612 * (510) 628-0100 |
| Business Description | The company is a leading provider of genomic information and bioinformatics analysis technologies. |
|
Filing Information Not yet | |||
| To Trade As | DBLT (NASNTL) | Industry | Pharmaceutical |
| Type of Stock Offered | Common Shares | Filing Date | 9/1/00 |
| Domestic Shares Filed | 5,000,000 | Filing Range | $13.00 - $15.00 |
| Foreign Shares Filed | 0 | Offering Amount | $70,000,000 |
| Company Shares | 5,000,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | 24,211,625 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Lehman Brothers Incorporated | Lead Manager | (212) 526-8100 |
| Dain Rauscher Wessels | Co-manager | (612) 371-2818 |
| Fidelity Capital Markets | Co-manager | |
| Thomas Weisel Partners LLC | Co-manager | (415) 364-2500 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/97 | 12/31/98 | 12/31/99 | 6/30/99 | 6/30/00 | ||
| Revenues | - | - | 1.276 | 4.252 | 3.584 | 1.870 | 2.806 |
| Income from Oper. | - | - | 9.515 | -8.253 | -11.572 | -4.150 | -14.371 |
| Net Income | - | - | -8.115 | -8.702 | -11.481 | -4.057 | -37.570 |
| E.P.S | - | - | -37.400 | -13.490 | -16.590 | -5.930 | -22.730 |
| Revenue Growth (%) | - | - | 233.23 | -15.710 | 50.05 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | 745.69 | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -7.88 | -2.64 | -10.65 | ||||
| Cash Flow - Inv. | -3.36 | -0.52 | -16.88 | ||||
| Cash Flow - Fin. | 2.23 | 3.26 | 41.13 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/00 | Financial Ratios | ||||
| Total Assets | 38.40 | Current Assets | 25.09 | Current Ratio | 3.69 |
| Total Liab. | 77.18 | Current Liab. | 6.80 | Debt Ratio | 200.97% |
| Total Equity | -38.77 | Working Cap. | 18.29 | Debt to Equity Ratio | - |
| Cash | 14.69 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to enhance existing products and develop new products, expand sales and marketing activities and for general corporate purposes, including working capital, technology enhancements and possible acquisitions of, or investments in companies, technologies or assets that complement business. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Heller, Ehrman, White & McAuliffe |
| Bank's Law Firm | Shearman & Sterling |
| Registrar/Transfer Agent | Harris Trust Company of California |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Institutional Venture Partners | 11.30 | |
| MDS Capital Corp. | 11.20 | |
| Mayfield Field | 11.10 | |
| Boston Millennia Partners | 9.90 | |
| MFM Capital LP | 8.70 | |
| Kleiner Perkins Caufield & Byers | 6.90 | |
| T Rowe Price Associates, Inc. | 5.20 | |
| Note: represents ownership of 5% or more prior to the offering. | ||